Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Classical hematology 1

Conditions

Multiple Myeloma 63Immunoglobulin Light-chain Amyloidosis 6Smoldering Multiple Myeloma 4Plasmacytoma 3Leukemia, Plasma Cell 3Recurrence 2Neoplasms, Plasma Cell 2Vomiting 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Sezary Syndrome 1Renal Insufficiency 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1POEMS Syndrome 1Ovarian Neoplasms 1Neuroblastoma 1Nausea 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Epoetin Alfa 10Darbepoetin alfa 4Therapeutics 2Filgrastim 2Ferric Oxide, Saccharated 2Cyclophosphamide 2Busulfan 2venetoclax 1trametinib 1ruxolitinib 1reolysin 1regorafenib 1ponatinib 1pertuzumab 1pembrolizumab 1palbociclib 1olaparib 1neratinib 1lorlatinib 1lenvatinib 1idelalisib 1fludarabine phosphate 1fludarabine 1ferrous sulfate 1ferric gluconate 1epoetin beta 1enzalutamide 1entrectinib 1enasidenib 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia × dexamethasone 21-phosphate × Plasma cell × Clear all
NCT02101944 2024-05-17

Wild-Type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

National Cancer Institute (NCI)

Phase 1 Completed
12 enrolled
Classical hematologyPlasma cell

Anemia, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡